Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
Edmund Omoruyi, Maya H Buch, Jane Barry, Laura Akroyd et al.
Citations
2 citations
Journal
Lara D. Veeken
Topics
Chronic Lymphocytic Leukemia Research
Field-Weighted Citation Impact (FWCI)
0.88
article
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
Edmund Omoruyi, Maya H Buch, Jane Barry, Laura Akroyd, Christopher J Edwards, Peter C. Taylor, David Walker
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Lara D. VeekenVol. 64(4)
Institutions
Northumbria Healthcare NHS Foundation Trust (GB), Nuffield Orthopaedic Centre (GB), University Hospital Southampton NHS Foundation Trust (GB), University of Oxford (GB), Manchester University NHS Foundation Trust (GB), NIHR Southampton Biomedical Research Centre (GB), NIHR Manchester Biomedical Research Centre (GB), Galapagos (Belgium) (BE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate — Edmund Omoruyi, Maya H Buch, et al. · Lara D. Veeken (2024) | TGRS Research Map | TGRS